
TrumpRx.gov aims to slash U.S. drug prices via MFN discounts
President Trump launched TrumpRx.gov to offer steep discounts on 40 high-cost medicines by tying U.S. prices to MFN prices paid in other developed nations. The rollout includes drugs from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, with additional products to follow. Patients with prescriptions can access savings via printable or mobile coupons or through manufacturer channels integrated into TrumpRx.gov. Notable examples include large price cuts for diabetes, obesity, fertility, COPD, asthma, and insulin, such as Ozempic, Wegovy, Zepbound, Gonal-F, Cetrotide, Ovidrel, and insulin lispro. The move builds on prior executive orders and agreements aimed at lowering prices and reforming how American drug costs are set.













